# PubMed record PMID 41337722

> PeptideScanner retained PubMed bibliographic metadata for PMID 41337722 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41337722-maridebart-cafraglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-03-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41337722-maridebart-cafraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41337722-maridebart-cafraglutide-v1.json
- Content SHA-256: `b5e5575f72e4336ed3bbc21ec9a0476164a443264d9f29458106bb0f93d1931c`

## Claims and source pins

### Headline

PubMed record PMID 41337722 ([`pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092`](#source-pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41337722 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092`](#source-pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41337722 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092`](#source-pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092`](#source-pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092))

## Sources

<a id="source-pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092"></a>
- **PubMed record PMID 41337722 · retained source version 1:2026-03-04:current:f7b75bc790922f4acc4a637f4e9e6977d30ccd90eace9b7c8f65b20018d96633** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41337722/) (`pubmed-observation-pmid-41337722-2026-03-04-f7b75bc79092`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 41337722." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41337722-maridebart-cafraglutide-v1.json SHA-256: b5e5575f72e4336ed3bbc21ec9a0476164a443264d9f29458106bb0f93d1931c.